Baricitinib in Symptomatic Patients Infected by COVID-19: an Open-label, Pilot Study.

Name: Baricitinib in Symptomatic Patients Infected by COVID-19: an Open-label, Pilot Study.
License: Public Domain

Hospital of Prato · clinicaltrials

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

pharmacological action

ClinicalTrials.gov Show glossary Search for terms Hide glossary Study record managers: refer to the Data Element Definitions if submitting registration or results information.

Record · ID 123572 · SHA-256 e5bfa50054351e7a
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.